This is a review about Flt-1, based on 29 published articles (read how Labome selects the articles), using Flt-1 antibody in all methods. It is aimed to help Labome visitors find the most suited Flt-1 antibody.
Flt-1 synonym: FLT; FLT-1; VEGFR-1; VEGFR1; fms-like tyrosine kinase 1; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor); tyrosine-protein kinase FRT; tyrosine-protein kinase receptor FLT; vascular permeability factor receptor

Santa Cruz Biotechnology
rabbit polyclonal (C-17)
  • WB; human
Santa Cruz Biotechnology Flt-1 antibody (Santa Cruz Biotechnology, sc-316) was used in western blot on human samples. PLoS ONE (2015) ncbi
rabbit polyclonal (C-17)
  • Neut; rat; 1:50
In order to report the signaling mechanisms by which PKC-zeta activation affects EMAP-II-induced BTB hyperpermeability, Santa Cruz Biotechnology Flt-1 antibody (Santa Cruz, sc-316) was used in neutralization on rat samples at 1:50. Exp Cell Res (2015) ncbi
rabbit polyclonal (C-17)
  • IHC-Free; rat; 1:500
  • WB; rat; 1:500
Santa Cruz Biotechnology Flt-1 antibody (Santa Cruz, sc-316) was used in immunohistochemistry - free floating section on rat samples at 1:500 and in western blot on rat samples at 1:500. Biomed Res Int (2014) ncbi
rabbit polyclonal (H-225)
  • WB; rat; 1:200; fig 5
In order to study the role of vascular endothelial growth factor A in ovarian hyperstimulation syndrome, Santa Cruz Biotechnology Flt-1 antibody (Santa Cruz Biotechnology, sc-9029) was used in western blot on rat samples at 1:200 (fig 5). J Steroid Biochem Mol Biol (2014) ncbi
rabbit polyclonal (C-17)
  • WB; human
In order to investigate the role of lipolysis stimulated lipoprotein receptor in aggressive breast cancer behavior, Santa Cruz Biotechnology Flt-1 antibody (Santa Cruz Biotechnology, SC316) was used in western blot on human samples. PLoS ONE (2014) ncbi
rabbit polyclonal (H-225)
  • WB; human
Santa Cruz Biotechnology Flt-1 antibody (Santa Cruz, sc-9029) was used in western blot on human samples. J Steroid Biochem Mol Biol (2014) ncbi
rabbit polyclonal (C-17)
  • WB; cow
Santa Cruz Biotechnology Flt-1 antibody (Santa Cruz, sc-316) was used in western blot on cow samples. Domest Anim Endocrinol (2013) ncbi
not indicated
  • IHC; human
Santa Cruz Biotechnology rabbit polyclonal anti-Flt-1 (VEGFR-1) antibody (C-17, sc316) was used in immunohistochemistry to investigate the expressions of EGFR and pEGFR and their correlation with overall and disease-free survival, clinicopathological parameters and biological markers of invasion and angiogenesis.Breast Cancer Res (2008) ncbi
not indicated
  • IHC; human
Santa Cruz Biotechnology polyclonal anti-flt-1 (1:1000) antibody was used to perform immunohistochemistry in order to study the functions and relations of vascular endothelial growth factor (VEGF), advanced glycation end products (AGEs), VEGF receptor (flt-1), and macrophages in the progress of proliferative diabetic retinopathy.Diabetes Res Clin Pract (2008) ncbi
not indicated
  • WB; human
  • IHC; human
Santa Cruz Biotechnology Flt-1 antibody was used in western blot and immunohistochemistry to study the role of placenta growth factor in malignancy.Mol Cancer Ther (2007) ncbi
not indicated
  • WB; human
  • IP; human
Santa Cruz Biotechnology rabbit and goat polyclonal anti-FLT-1 antibody was used in western blot and immunoprecipitation to detect FLT-1 in serum-starved PAE cells expressing FLT-1 and VEGFR-2.J Biol Chem (2006) ncbi
not indicated
  • WB; human
Santa Cruz Biotechnology anti-Flt-1 antibody was used in western blot to study the role for dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling in human umbilical vein endothelial cells (HUVECs).FASEB J (2005) ncbi
not indicated
  • WB; human
SCBT anti-FLT1 antibody was used in western blot to investigate the regulatoin of VEGFR2/KDR by KLF2J Biol Chem (2005) ncbi
not indicated
  • WB; human
  • IP; human
Santa Cruz Biotechnology antibody to FLT-1 was used in immunoprecipitation to isolate FLT-1 from human breast cancer cell lines BT474, MDA-MB-231, MDA-MB-435, and SK-BR3, and in western blot to detect FLT-1 expression in human breast carcinoma MDA-MB-231 cells.Neoplasia (2005) ncbi
Abcam
rabbit monoclonal (Y103)
  • WB; mouse
In order to assess the role of receptor-interacting protein 2 in VEGF signalling and myocardial ischaemia/reperfusion injury, Abcam Flt-1 antibody (Abcam, ab32152) was used in western blot on mouse samples. Cardiovasc Res (2015) ncbi
rabbit monoclonal (Y103)
  • IHC; human
  • IC; human
Abcam Flt-1 antibody (Abcam, ab32152) was used in immunohistochemistry on human samples and in immunocytochemistry on human samples. Biomaterials (2014) ncbi
rabbit monoclonal (Y103)
  • FC; rat
  • IC; rat
Abcam Flt-1 antibody (Abcam, ab32152) was used in flow cytometry on rat samples and in immunocytochemistry on rat samples. Vasc Cell (2014) ncbi
rabbit monoclonal (Y103)
  • WB; human
Abcam Flt-1 antibody (Abcam, ab32152) was used in western blot on human samples. Mol Cancer Ther (2013) ncbi
EMD Millipore
mouse monoclonal (BK302)
  • WB; rat; 1:200
EMD Millipore Flt-1 antibody (Millipore, 05-696) was used in western blot on rat samples at 1:200. Ann Anat (2015) ncbi
rabbit polyclonal
  • IHC-P; human
EMD Millipore Flt-1 antibody (Millipore, 07-758) was used in immunohistochemistry - paraffin section on human samples. Oncotarget (2014) ncbi
R and D Systems
goat polyclonal
  • IHC-P; mouse; 1:100
In order to evaluate an animal model for periventricular leukomalacia, R and D Systems Flt-1 antibody (R&D, Af321) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. J Clin Invest (2015) ncbi
goat polyclonal
  • IHC-P; human; 1:20
R and D Systems Flt-1 antibody (R&D Systems, AF321) was used in immunohistochemistry - paraffin section on human samples at 1:20. Am J Pathol (2014) ncbi
R&D Systems sFlt-1 ELISA kit was used to quantify the mount of soluble Flt-1 in maternal plasma samples in order to investigate the role for VEGF165b as trimester predictive marker for pre-eclampsia.Clin Sci (Lond) (2009) ncbi
goat polyclonal
  • IHC; human
R&D Systems goat anti-human VEGFR-1 polyclonal antibody (catalog number: AF321) was used to perform immunochemistry assays in order to demonstrate that VEGFR-1 expression is not related to the risk of cancer progression following radical prostatectomy.Oncol Rep (2008) ncbi
Invitrogen
rabbit polyclonal
  • IC; human
In order to isolate and characterize PDGFR-beta(+) perivascular cells from infantile hemangioma, Invitrogen Flt-1 antibody (Thermo Scientific, RB-1527) was used in immunocytochemistry on human samples. Int J Clin Exp Pathol (2014) ncbi
rabbit polyclonal
  • IC; human
In order to test if MSCs in hemangioma also reside in the perivascular region, Invitrogen Flt-1 antibody (Thermo Scientific, RB-1527) was used in immunocytochemistry on human samples. Pediatr Dev Pathol (2012) ncbi
rabbit polyclonal
  • IHC; human; fig 2
In order to discuss pericellular retention of sVEGF-R1, Invitrogen Flt-1 antibody (Zymed, 36-1100) was used in immunohistochemistry on human samples (fig 2). Circ Res (2011) ncbi
Abbiotec
rabbit polyclonal
  • IHC-P; mouse
Abbiotec Flt-1 antibody (Abbiotec, 250908) was used in immunohistochemistry - paraffin section on mouse samples. Am J Physiol Renal Physiol (2013) ncbi
WILEX Inc.
not indicated
  • IHC; human
Oncogene rabbit anti-phosphorylated VEGFR1 (Flk-1) antibody was used in immunohistochemistry to study whether the expression of tyrosine kinase growth factor receptors is constant or varies between and within individual colon cancer neoplasms.Am J Pathol (2008) ncbi
Articles Reviewed
  1. Linda Andersson et al. (2015). "Rip2 modifies VEGF-induced signalling and vascular permeability in myocardial ischaemia".PMID 26130752
  2. Shota Yamana et al. (2015). "The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation".PMID 25893857
  3. Tamar Licht et al. (2015). "Vessel maturation schedule determines vulnerability to neuronal injuries of prematurity".PMID 25689256
  4. Zhen Li et al. (2015). "Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism".PMID 25592443
  5. Asli Ozmen et al. (2015). "Glucocorticoid exposure altered angiogenic factor expression via Akt/mTOR pathway in rat placenta".PMID 25479925
  6. Monique C P Mendonça et al. (2014). "Vascular endothelial growth factor increases during blood-brain barrier-enhanced permeability caused by Phoneutria nigriventer spider venom".PMID 25247186
  7. Leopoldina Scotti et al. (2014). "Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome".PMID 25151950
  8. Si Ming Yuan et al. (2014). "PDGFR-β (+) perivascular cells from infantile hemangioma display the features of mesenchymal stem cells and show stronger adipogenic potential in vitro and in vivo".PMID 25031705
  9. Paul Mésange et al. (2014). "Intrinsic bevacizumab resistance is associated with prolonged activation of autocrine VEGF signaling and hypoxia tolerance in colorectal cancer cells and can be overcome by nintedanib, a small molecule angiokinase inhibitor".PMID 25015210
  10. Anjaneyulu Dirisala et al. (2014). "Optimized rod length of polyplex micelles for maximizing transfection efficiency and their performance in systemic gene therapy against stroma-rich pancreatic tumors".PMID 24720877
  11. Denise K Reaves et al. (2014). "The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior".PMID 24637461
  12. Eimear Kennedy et al. (2014). "Embryonic rat vascular smooth muscle cells revisited - a model for neonatal, neointimal SMC or differentiated vascular stem cells?".PMID 24628920
  13. Allison R Larson et al. (2014). "Melanoma spheroid formation involves laminin-associated vasculogenic mimicry".PMID 24332013
  14. Weijie Zhong et al. (2014). "Activation of vitamin D receptor promotes VEGF and CuZn-SOD expression in endothelial cells".PMID 24316428
  15. L A Fátima et al. (2013). "FSH up-regulates angiogenic factors in luteal cells of buffaloes".PMID 24209507
  16. Sandeep Sreevalsan et al. (2013). "The cannabinoid WIN 55,212-2 decreases specificity protein transcription factors and the oncogenic cap protein eIF4E in colon cancer cells".PMID 24030632
  17. Robert T Day et al. (2013). "Apelin retards the progression of diabetic nephropathy".PMID 23303408
  18. Si Ming Yuan et al. (2012). "Mesenchymal stem cells in infantile hemangioma reside in the perivascular region".PMID 21689017
  19. Shay Sela et al. (2011). "Local retention versus systemic release of soluble VEGF receptor-1 are mediated by heparin-binding and regulated by heparanase".PMID 21415391
  20. Victoria L Bills et al. (2009). "Failure to up-regulate VEGF165b in maternal plasma is a first trimester predictive marker for pre-eclampsia".PMID 18826376
  21. Christina Magkou et al. (2008). "Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas".PMID 18522728
  22. Toshio Kuwai et al. (2008). "Intratumoral heterogeneity for expression of tyrosine kinase growth factor receptors in human colon cancer surgical specimens and orthotopic tumors".PMID 18202197
  23. Kaili Mao et al. (2008). "The association of vascular endothelial growth factor receptor-1 with the risk of cancer progression following radical prostatectomy".PMID 18097592
  24. Akihiro Kakehashi et al. (2008). "Relationship among VEGF, VEGF receptor, AGEs, and macrophages in proliferative diabetic retinopathy".PMID 18053608
  25. Alice P Taylor et al. (2007). "Role of placenta growth factor in malignancy and evidence that an antagonistic PlGF/Flt-1 peptide inhibits the growth and metastasis of human breast cancer xenografts".PMID 17308051
  26. Rosana D Meyer et al. (2006). "A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1".PMID 16286478
  27. Resham Bhattacharya et al. (2005). "Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling".PMID 16049137
  28. Resham Bhattacharya et al. (2005). "Inhibition of vascular permeability factor/vascular endothelial growth factor-mediated angiogenesis by the Kruppel-like factor KLF2".PMID 15980434
  29. Sophia Ran et al. (2005). "The vascular-ablative agent VEGF(121)/rGel inhibits pulmonary metastases of MDA-MB-231 breast tumors".PMID 15967101